This inventor holds 4 USPTO granted patents. Top assignee: Mitsui Toatsu Chemicals, Incorporated. Active years: 1987-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1989
Title: **Masahiko Maruyama: A Pioneer in Pharmacological Patents**
Introduction
Masahiko Maruyama is a notable inventor based in Chiba, Japan, with a strong focus on developing compounds that have significant implications in the pharmaceutical industry. With a total of four patents to his name, Maruyama has made remarkable contributions that enhance the efficacy of heart medications.
Latest Patents
Among his latest innovations are the pyridyl-cyclohexanone compounds and isoquinoline derivatives. The pyridyl-cyclohexanone compounds are characterized by a specific general formula, where R can be a hydrogen atom or an acetyl group. These derivatives act as essential intermediates in producing isoquinoline derivatives, which are particularly important as drugs, especially in cardiac treatments. Meanwhile, the isoquinoline derivative patent details a compound that includes various substitutions such as methyl, methoxymethyl, and other groups, which are particularly noted for their low toxicity and high efficacy as cardiotonic medications.
Career Highlights
Masahiko Maruyama is affiliated with Mitsui Toatsu Chemicals, Incorporated, a company known for its commitment to innovation in chemical products. His work there has positioned him at the forefront of pharmaceutical development, integrating chemistry and medicine to create life-saving pharmaceuticals.
Collaborations
In his journey of innovation, Maruyama has collaborated with distinguished coworkers such as Makoto Hirayama and Takafumi Kitano. Together, they have pursued research that pushes the boundaries of current medicinal chemistry and enhances the therapeutic profiles of essential drugs.
Conclusion
Masahiko Maruyama exemplifies the ideal inventor whose work not only advances scientific understanding but also greatly impacts patient care through innovative drug development. With his continued efforts at Mitsui Toatsu Chemicals, he remains a key player in the advancement of pharmacological inventions that can potentially save lives and improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile